Tag Archives: RESI

Active Healthcare Investors and Strategic Partners Are Attending RESI San Diego

8 Jun

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

Life Science Nation (LSN) and Johnson and Johnson Innovation, JLABS have launched San Diego’s first Redefining Early Stage Investments (RESI) Conference on June 19th, 2017 during the 2017 BIO week when the biotech and medtech world gathers in San Diego. RESI San Diego will bring together 400+ fundraising CEOs and 400+ early stage investors (a 1:1 ratio) from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations. Register for RESI now.

Tags: , , , , , ,

Family Offices Converge on RESI to Meet Early Stage Biotech and Medtech Startups

8 Jun

By Lucy Parkinson, Director of Research, LSN

RESI is a venue where early stage life science startups can meet with investors of every type that are a fit for their company’s technology and stage – and that includes family offices. RESI San Diego features two panels devoted to this elusive investor class – Biotech Family Offices and Medtech Family Offices. Whether you’re developing a novel therapeutic, an innovative device or an improved diagnostic solution, Family Offices can’t be overlooked as a potential source of capital and RESI will provide you with the opportunity to hear advice and insight directly from key investment decision makers from family offices.

Biotech Family Offices, moderated by Colin Widen (CEO, Boston Innovation Capital), features:

Medtech Family Offices, moderated by Michael Quigley (VP of Market Research, Life Science Nation), features:

To catch this rare opportunity to meet family office investors with a focus on early stage life science investment, register for RESI now.

Tags: , , , , , ,

RESI Innovation Challenge: LSN’s Scientific Review Team Selects 30 Top Life Science Startups

1 Jun

By Christine A. Wu, Senior Research Analyst, LSN

chrsitine

We are pleased to announce our thirty finalists to compete in the Innovation Challenge at Life Science Nation’s (LSN) first-ever RESI in San Diego. From a pool of approximately 100 applicants, the LSN Scientific Review Team has selected a diverse group of life science startups: three healthcare IT, three diagnostic, thirteen therapeutic, and eleven medical device companies.  These startups will showcase themselves in the exhibit hall display spaces at RESI on June 19th. The quality of these companies should not go unnoticed, as we have seen nearly 50% of Innovation Challenge finalists from previous RESI’s receive funding within one year of their debut.

From personalized cancer immunotherapies to digital pathology imaging, these companies cover a diverse range of life science technologies. Coming from all over the world, the companies will be competing based on scientific merit and investment potential, pitching to RESI attendees and showcasing their innovations. Be sure to catch them and make your “investments” at the RESI Exhibition Hall in just a couple weeks!

Therapeutic
 
Diagnostic
Medical Device
 
Healthcare IT
 

Tags: , , ,

RESI San Diego: Biotech & Medtech Angels Discuss their Strategy

1 Jun

By Cole Bunn, Senior Research Analyst, LSN

cole-wp

Angel investors are a major force at the earliest stages of financing for life science companies, and can have a great influence in startup development. As many of these individuals have been entrepreneurs and often take an operational role along with an investment, their capital, network and know-how is crucial for energizing a new venture and ensuring that the company has all its ducks in a row as it goes on to grow as a business and raise more capital.

Given the significant differences in the development and financing needs of biotech vs. medtech companies, LSN has two separate sessions which showcase active angles in each space separately.

The Biotech Angels panel will be moderated by Bernie Rudnick, Founder, Mid Atlantic Bio Angels and will feature the following panelists:

The Medtech Angels panel will be moderated by Brian Frenzel, Member, Band of Angels and will feature the following panelists:

These panel sessions will explore general topics such as how angel groups approach an investment opportunity and how best to pitch to/work with an angel investor as well as more specific topics such as how they work with other angel groups and VCs, what to expect in the diligence process, cap table issues and more.

Tags: , , , ,

RESI San Diego Panel: Corporate Venture Capital

1 Jun

By Lucy Parkinson, Director of Research, LSN

Corporate venture capital funds have been a key pillar of the life science investment community for some time, and at LSN we’ve seen these groups evolving on strategy to keep up with an increasingly competitive investor marketplace. While many pharma firms still use corporate VC as a strategic vehicle for filling pipelines, these firms are increasingly collaborative and keen to be seen as aligned with the interests of entrepreneurs and other investors, as well as those of their parent companies.

At RESI, a panel of 5 top corporate VCs from around the world will explain how their group makes strategic investments in early stage companies, and how a corporate VC relationship can help a startup company get ahead in development and strategic relationships.

Moderated by Rajeev Dadoo (Partner, SR One), the participants are:

Tags: , , , ,

Medical Device Investors Share Their Expert Advice at RESI San Diego

25 May

By Lucy Parkinson, Director of Research, LSN

The medical device industry is consolidating rapidly, and many entrepreneurs find the medtech fundraising landscape challenging to navigate.  However, there are a great diversity of early stage device investors out there looking for deals. This RESI panel brings together device investors from US and international VCs, a major device firm, and a private investment group to discuss how they assess medical device opportunities, and how an entrepreneur can build a productive dialogue with their firm.

Moderated by David Cassak (CEO, Innovation In Medtech), the panelists are:

Tags: , , , ,

RESI Partnering Opens Monday 5/22 – The Early Entrepreneur Gets the Meetings

18 May

By Michael Quigley, VP of Market Research, LSN

mike-2RESI Partnering goes live on Monday, enabling fundraising life science executives and the investors who fund them to request meetings with one another on the basis of mutual fit. By getting into the system on day one you have the opportunity of being the first to request meetings, thus increasing your chances of being considered and getting the best meetings possible.

Powered by LSN’s proprietary investor data, the RESI partnering platform offers you something no other conference provider can, qualified forward-looking data on what investors are looking for. This data is one of several ingredients in RESI’s secret sauce that enables us to make so many meaningful connections (over 1500 per event!) between fundraising executives and investors.

Just getting in early isn’t enough to secure the most meaningful meetings as possible. We have been studying our partnering analytics since RESI 1, and after 12 RESI events we have proved that….big surprise….the more meeting requests you send out, the more meetings you will secure. The chart below shows the relationship between requests sent and meetings confirmed at a previous RESI event. Science and data minded folks, see for yourself!

And if all that isn’t enough to get you sign up, note that if you sign up by Friday May 19th you can beat the $200 price increase. I hope to see you all buzzing in the partnering hall in San Diego this June 19th.

Click Here to Register Now

Tags: , , , ,

← Older Entries
Newer Entries →